The M1 protein is a major structural protein that has multiple functions in various steps within the life cycle of the influenza A virus (IAV). However, little is currently known about the role of M1 in IAV replication in vivo and the associated pathogenesis. In this study, six isogenic H1N1 WSN33 viruses, constructed to express unique M1 proteins derived from various strains, subtypes or WSN33 itself, were tested to determine in vitro and in vivo functional exchangeability of M1 proteins in the replication and pathogenesis of the WSN33 virus. Despite five chimeric M1 viruses replicating to levels similar to those of the parental WSN33 virus in cell cultures, all M1 chimeras exhibited improved replication and enhanced virulence in mice when compared with the WSN33 virus. Interestingly, M1 proteins derived from swine viruses caused more severe clinical diseases than those from human or quail. These data indicate that the M1 protein is an important determinant of viral replication and pathogenic properties in mice, although the functions of M1 observed in vivo are not adequately reflected in simple infections of cultured cells. Chimeric M1 viruses that are variable in their clinical manifestations described here will aid future understanding of the role of M1 in IAV pathogenesis.
INTRODUCTION
The M1 protein of the influenza A virus (IAV) is the most abundant protein of the virion and forms a bridge-like membrane matrix that structurally and functionally connects the internal viral ribonucleoprotein (vRNP) core and external viral envelope proteins (Nayak et al., 2009) . The M1 protein is instrumental in orchestrating the virus life cycle. This orchestration is believed to be achieved through M1-mediated interactions with other viral proteins, viral RNA, cellular proteins and lipid (Akarsu et al., 2003; Ali et al., 2000; Avalos et al., 1997; Bui et al., 2000; Chen et al., 2008; Demirov et al., 2012; Elster et al., 1997; Enami et al., 1994; Hirayama et al., 2004; Huang et al., 2009; Liu et al., 2009; Noton et al., 2007; Pal et al., 2011; Reinhardt & Wolff, 2000; Roberts et al., 1998; Ruigrok et al., 2000; Watanabe et al., 2006; Wu et al., 2011; Zhao et al., 1998; Zhirnov & Klenk, 1997) . Despite mechanisms that
are not yet fully understood, it is generally believed that during virus entry M1 must undergo low pH-induced structural transition in the endosomal compartment probably from high-order and stable oligomers to unstable M1 monomers (Bui et al., 1996; Calder et al., 2010; Fontana et al., 2012; Zhirnov, 1992) . Disassociation of the M1 protein shell facilitates release of vRNPs to the cytoplasm so they can enter the nucleus and initiate viral genome transcription and replication (Bui et al., 1996; Martin & Helenius, 1991b) . The newly synthesized M1 protein migrates to the nucleus and subsequently binds to vRNPs through the nuclear export protein, which directs nucleocytoplasmic transport of vRNP complexes (Akarsu et al., 2003; Bucher et al., 1989; Elton et al., 2001; Neumann et al., 2000; O'Neill et al., 1998; Yasuda et al., 1993) . In addition, M1 present in the cytoplasm also interacts with vRNPs via viral RNA or nucleoprotein (Baudin et al., 2001 ; (Perez & Donis, 1998; Watanabe et al., 1996) . This latter event converts IAV replication from viral genome transcription to virus assembly and budding. The role of M1 in the final stage of the virus life cycle is currently unclear, as recent studies have demonstrated that M1 is not required for budding of IAV virus-like particles (Chen et al., 2007; Wang et al., 2010) . Despite this fact, the M1 protein plays an indisputable role in determining viral morphology. Its unique topology in the virion implicates M1 as a key player in coordinating discrete steps during the assembly and budding of IAV (Calder et al., 2010; Elleman & Barclay, 2004; Roberts et al., 1998) .
In addition to its structural and regulatory roles, the M1 protein has also been shown to be involved in host adaptation, as well as contributing to the virulence of IAVs (Buckler-White et al., 1986; Fan et al., 2009; Furuse et al., 2009; Lee et al., 2001; McCullers et al., 2005; Murphy et al., 1989; Reid et al., 2002; Ward, 1995 Ward, , 1996 Ward, , 1997 . For example, an earlier study reported that M1 contributed to restrict the replication of an avian IAV in monkeys (Buckler-White et al., 1986) . A cluster of mutations, centring largely on the C-terminal domain of M1, have been implicated as determinants for advantageous growth in mice and subsequent acquisition of virulence (Brown et al., 2001; Govorkova et al., 2000) . Perhaps the most significant finding that links M1 with viral pathogenesis was discovered during the study of the influenza B virus, where McCullers et al. (2005) demonstrated that a single amino acid change in the C-terminal domain of M1 conferred mouse adaptation and virulence of influenza B virus. Recent observations that the M segment from pandemic H1N1 (pH1N1) promotes efficient spread of reassortant viruses in animal models, including pig and guinea pig, seem to further support the essential role of M1 in the replication, transmission and pathogenesis of influenza viruses (Chou et al., 2011; Ducatez et al., 2011; Ma et al., 2012) .
The M1 protein contains 252 aa and is the most conserved protein found in IAV. Despite their conserved nature, the M1 proteins of IAVs exhibit up to 20 % amino acid sequence variation (http://www.ncbi.nlm.nih.gov/genomes/FLU/FLU. html). Little is known about the role of M1-associated sequence variation in IAV replication and virulence. In this study, we constructed six isogenic recombinant influenza H1N1 WSN33 viruses that differed only in their M1 proteins, which were derived from various strains of different subtypes or originated from WSN33 itself. The chimeric M1 viruses were examined in detail in terms of replication kinetics in cell cultures as well as replication and virulence properties in a mouse model. Results from our experiments showed that despite similar levels of replication in vitro, the chimeric viruses exhibited different patterns of replication and virulence in mice. Thus, these observations suggest in vivo functions of different M1 proteins that are not adequately reflected in simple infections of culture cells, and provide compelling evidence that the M1 protein of IAV is a determinant of viral replication and virulence properties in experimentally infected mice.
RESULTS
Generation of wild-type (WT), recombinant M-segment and chimeric M1 WSN33 viruses Two groups of viruses, in addition to WT WSN33, were generated to address the impact on the replication of IAV, resulting from functional replacement of different M1 proteins. The first group involved substitutions of the WSN33 M segment with its counterparts from the following viruses: influenza A/Swine/Iowa/15/30 (H1N1), A/Swine/Missouri/4296424/06 (H2N3), A/Swine/Texas/ 4199-2/98 (H3N2), A/California/04/09 (H1N1) and A/ Quail/Hong Kong/G1/97 (H9N2). The second group consisted of six isogenic WSN viruses, differing only in their M1 proteins, which were derived from the viruses in the first group. To generate the second group of viruses, a PCR-ligation-PCR technique was used to introduce M1 coding sequences from other viruses to the parental WSN33 M segment in a way that did not alter its M2 coding sequence ( Fig. 1) (Chen et al., 2001; Li et al., 2002) . Stocks of these viruses were generated by reverse genetics and titrated in Madin-Darby canine kidney (MDCK) cells by plaque assay as described in Methods.
In vitro characterization of recombinant M-segment and chimeric M1 WSN33 viruses Fig. 2 summarizes the growth kinetics experiments of WT and mutant WSN33 viruses. In general, all recombinant Msegment and chimeric M1 viruses replicated in a similar fashion as the WT rWSN in infected MDCK cells with the notable exception of rWSN-HK97M1. rWSN-HK97M1 displayed a 36 h lag relative to WT and other M1 chimeric viruses and appeared not to be able to reach a WT-like peak level of virus replication observed during the timecourse of the experiments. Despite this difference, our results collectively suggested that the WSN33 M segment or M1 protein can be functionally replaced by its counterparts from other IAVs in vitro. Considering that the focus of this study was on the M1 protein, we further characterized in vivo replication and virulence properties of WT WSN33 and chimeric M1 viruses.
In vivo functional exchangeability of M1 proteins in influenza WSN33 virus replication
We used a mouse model to study replication and pathogenicity of isogenic WSN33 viruses differing only in M1 proteins. Six groups, each consisting of 13 mice, were inoculated intranasally with 5610 3 p.f.u. of rWSN, rWSN-IA30M1, rWSN-HK97M1, rWSN-TX98M1, rWSN-MO06M1 and rWSN-CA09M1. In the control group, 13 mice were inoculated with virus-free minimal essential medium (MEM) by the same intranasal route. We selected this particular infection dose because we speculated that a low viral inoculum in mice could maximize an animal's sensitivity to virus replication and the associated virulence, allowing slight changes in M1 protein to be detected by changes in virulence in mice.
rWSN-infected mice did not show clear clinical symptoms and only displayed a slight weight loss starting at day 7 post-infection (p.i.); however, all the mice regained the weight by day 11 p.i. (Fig. 3a) . None of mice in this group succumbed to infection over a period of 14 days p.i. Modest levels of disease may have been caused by a relative low dose of virus inoculum (i.e. 5610
3 ). Inoculation of mice with similar doses of WSN33 virus resulting in neither detectable weight loss nor death has been previously reported in a recent study (Garcia et al., 2010) . In marked contrast, all the mice in our study inoculated with M1 chimeras exhibited substantial weight loss starting at day 4 p.i., and visible clinical symptoms including ruffled fur, lethargy, anorexia and dyspnoea were observed. Despite being significantly pathogenic in mice, the five M1 chimeric viruses behaved differently in conferring virulence in the mice, measured by survival rate (Fig. 3b ). Among these, rWSN-IA30M1 and rWSN-TX98M1 appeared to be more virulent, as all the mice inoculated with these two viruses succumbed to infection or reached the experimental end point by days 10 and 12 p.i., respectively. rWSN-MO06M1 also exhibited relatively high virulence as it caused approximately 80 % mortality of mice. Two chimeric rWSN-HK97M1 and rWSN-CA09M1 viruses seemed to possess a moderate virulence as approximately 40-55 % of infected mice survived their infections over the 14 day observation period. It is interesting to note that the mice study did not reproduce an attenuated phenotype of rWSN-HK97M1 as demonstrated in MDCK cells (Fig. 2b ) (compared with the WT WSN33). Despite an unknown mechanism, we suspect that the rWSN-HK97M1 protein may not interact with its cellular targets in MDCK cells as efficiently as those in mice, which are required for optimal virus replication. Taken together, these data demonstrate an M1-dependent virulence phenomenon in mice, highlighting the important role of the M1 protein in IAV pathogenesis.
The severity of influenza disease has been correlated closely with the levels of virus replication in experimentally infected mice. Therefore, we closely monitored the levels of virus replication in mouse lungs by TCID 50 ml 21 analysis in MDCK cells. Three mice from each group were sacrificed on both days 3 and 5 p.i., in this study. Notably, all mice inoculated with the five chimeric M1 viruses had significantly higher lung viral titres than those infected with the WSN33 virus by approximately 1 or 2 logs at both time points (Fig. 4a) . This finding suggests a reasonable association between the level of virus replication and disease severity in a mouse model of IAV infection.
However, we did not observe a strict correlation between these two parameters, particularly among mice inoculated with M1 chimeric viruses. For example, mean viral titre values in mice inoculated with rWSN-MO06M1 were found to be 1 log higher when compared with rWSN-IA30M1 on day 3 p.i.; however, rWSN-MO06M1 caused less mortality than rWSN-IA30M1 and similar discordance was also observed in other virus groups.
To further evaluate the pathogenesis of isogenic WSN33 viruses differing only in the M1 protein, we performed histopathological examination of infected mice lungs. The WT rWSN and chimeric M1 viruses induced pneumonia in infected mouse lungs (Figs 4b and 5). As shown in Fig.  4(b) , the severity of lung lesions determined by mean histological lesion scores as described previously (Liu et al., 2011) increased with time, suggesting progressive disease development due to virus replication. Overall, mice inoculated with M1 chimeric viruses developed histological lesion scores higher than that of the WT WSN33 inoculated group. Significant differences in histological lung lesions were observed between the WT rWSN and three M1 chimeric viruses (rWSN-CA09M1, rWSN-MO06M1 and rWSN-HK97M1) on day 3 p.i., and between the rWSN and three M1 chimeric (rWSN-CA09M1, rWSN-IA30M1 and rWSN-HK97M1) viruses on day 5 p.i. (Fig. 4b ). As noted in virus load analysis, there was no absolute correlation between lung lesion score and virulence among mice infected with M1 chimeras. For example, the rWSN-HK97M1 induced higher lung lesions in mouse lungs rather than rWSN-TX98M1, but it caused less mortality than the latter. Taken together, all these results demonstrate that M1 chimeric viruses gain better replication fitness and are more virulent in mice as compared with the WT WSN33.
Analysis of viral protein expression in chimeric and WT WSN33 viruses
In order to further determine whether chimeric viruses behave similarly to WT WSN33 virus in biological and biochemical properties, we next characterized these viruses for M1, haemagglutinin (HA) and neuraminidase (NA) protein expression. We infected MDCK cells with 1 m.o.i. of WT rWSN and M1 chimeras, respectively, and purified virions from culture supernatants collected 12 and 24 h p.i. Virions were analysed for M1 protein expression, HA activity and NA function. We chose 1 m.o.i. inoculum over 0.001 m.o.i. used for generation of growth kinetics data because the latter could not allow us to detect viral protein expression at 12 and 24 h following virus infection.
For M1 protein detection and quantification by Western blot assay, the expression level of WT rWSN M1 protein was arbitrarily set at 100 % and the M1 level for each chimeric virus was normalized by comparison with WT rWSN (Fig. 6a, b) . At 12 h p.i., all chimeras except for rWSN-HK97M1 exhibited nearly identical amounts of virion-associated M1 as that observed in WT rWSN. The We used a traditional haemagglutination assay to quantify the amount of HA protein in virions and also employed a fluorescence-based enzymic assay to measure the function of NA protein. As demonstrated in Table 1 and Fig. 6(c) , all chimeric viruses exhibited WT-like HA and NA activities at two time points with the exception of rWSN-HK97M1. This virus expressed NA protein very similar to WT rWSN but showed reduced HA titres: 1 log 2 and 2 log 2 lower relative to WT rWSN at 12 and 24 h p.i.
Results of our experiments demonstrated that all M1 chimeric viruses are similar to WT rWSN with regards to the expression of M1, NA and HA proteins, which is in good agreement with our in vitro cell-culture-based replication experiment. In replication kinetics we noted that rWSN-HK97M1 virus was slightly attenuated in comparison with WT rWSN and other chimeric viruses and this moderate attenuation is probably due to the reduction of M1 and HA proteins in virus particles.
DISCUSSION
Studies described here reveal a novel M1-dependent replication and virulence phenomenon of influenza A WSN33 H1N1 virus in a mammalian host. Thus, the results of our experiments suggest that the M1 protein is an important determinant for viral replication and pathogenic properties in vivo. These findings maintain a theme established by previous studies concerning a role of the M1 protein in IAV replication and pathogenesis (BucklerWhite et al., 1986; Fan et al., 2009; McCullers et al., 2005; Ward, 1995 Ward, , 1997 . The differences observed between the in vitro and in vivo phenotypes of the M1 chimeric viruses used in this study are interesting, and emphasize the importance of evaluating protein function under in vivo conditions, as in vitro cell culture assays may not detect critical in vivo properties of influenza viral proteins such as M1.
The M1 protein of IAV is a primary determinant for viral morphogenesis (Calder et al., 2010; Elleman & Barclay, 2004; Roberts et al., 1998) . It should be noted that we have not performed electron microscopy studies to define the morphology of these viruses, mainly due to our observation that these recombinant viruses replicated similarly to the WT virus in MDCK cells. It is likely that these viruses have a similar morphology. However, it is still possible that the described viruses may exhibit different morphologies including viral budding efficiency. Notable differences in viral morphogenesis contributing to viral replication might not be measurable in cell culture but can be detected and amplified in mice. Future study towards this aspect should help to define the molecular mechanism of M1-associated virulence.
It is believed that higher levels of viral replication are associated with more severe influenza disease. Results of our experiments in this study supported this established concept. For example, mice inoculated with chimeric M1 viruses showed more severe clinical symptoms compared with mice inoculated with the WSN33 virus. Additionally, the mice infected with the chimeric viruses produced virus at a level about 1 log higher than the mice infected with the WSN33 virus. However, our data also suggested that the relationship between disease severity and viral load is not absolute in all cases. For example, mice infected by M1 1997; Harris et al., 2001; Hui et al., 2006; Liu & Ye, 2005; Martin & Helenius, 1991a; Okada et al., 2003; Perez & Donis, 1998; Ye et al., 1995) . Through comparative analysis of the six M1 amino acid sequences used in this study (Fig.  7) , we found that these M1 proteins show up to an 11 % sequence divergence. We also noticed that unique variations between WSN33 M1 and other M1 proteins occur only at five positions, 41, 115, 126, 137 and 204 (Fig. 7) . M1 position 41, located in the M1 N domain, has been linked to a role in determining virion morphology (Elleman & Barclay, 2004; Roberts et al., 1998) . Early studies have shown that an A to V change at this position resulted in a loss in filamentous phenotype (Elleman & Barclay, 2004) . It remains unclear whether the other four positions are involved in virus replication and virulence, as none of these residues are located in a known functional domain of the M1 protein. Nevertheless, large-scale phylogenetic analyses of M1 sequences of IAVs from different subtypes or different hosts suggest that these positions, particularly 115, 126 and 137 located in the M1 M domain, might be involved in host adaptation and virulence (Furuse et al., 2009; Lam et al., 2008; Reid et al., 2002) . Addressing the impact of amino acid variations at these positions in the M1 protein on the observed disease enhancement poses great potential as a focus point in future study. In addition to these five positions, we also observed sequence variations in other locations among five M1 proteins introduced to WSN33 virus (data not shown). Investigating these mutations in the future is also important because it will help to elucidate the genetic basis of clinical disease progression rates in mice as observed among chimeric M1 viruses.
The M1 protein of IAV and M1-like proteins present in other enveloped RNA viruses are able to interact with both the internal core protein complex and the external viral envelope proteins due to their unique topology in the virion (Nayak et al., 2009; Rossman & Lamb, 2011) . In this regard, the primary role of these proteins is to act as a bridge to structurally and functionally coalesce various components into budding virions through mechanisms that are largely unknown to date (Nayak et al., 2009; Rossman & Lamb, 2011) . It has been clearly shown that the matrix protein of vesicular stomatitis virus (VSV) also plays a key role in evading the host innate immune response (Faul et al., 2009) . The ability of VSV M protein to inhibit the host alpha interferon/beta interferon response is genetically separable from its role in virus structure and assembly (Black et al., 1993 ). An interesting thought for the future would be to design similar experiments to address whether the M1 protein of IAV can inhibit host innate immunity. If this is found to be true, could amino acid variations at the five aforementioned positions of the M1 protein impact M1's ability in overcoming host innate immune response that may result in different clinical outcomes? Future elucidation of these questions will provide insights into the pathobiology of IAV M1 protein.
METHODS
Cells, virus and animals. MDCK and 293T human embryonic kidney cells were grown in Dulbecco's modified Eagle's medium (DMEM) containing 10 % FBS at 37 uC with 5 % CO 2 . Influenza virus A/WSN/33 (H1N1) was generated by using the reverse genetic system that contains eight plasmids (pHW181-PB2, pHW182-PB1, pHW183-PA, pHW184-HA, pHW185-NP, pHW186-NA, pHW187-M and pHW188-NS), which was kindly provided by E. Hoffmann, St Jude Children's Research Hospital. Virus was propagated in MDCK cells at an m.o.i. of 0.001. Six-week-old female BALB/c mice were purchased from Charles River Farms.
RT-PCR and sequencing. Viral RNA was extracted from collected cell-culture supernatants with the QIAamp viral RNA kit (Qiagen). Purified RNA was treated with DNase I (Ambion) at 37 uC for 30 min for complete removal of potential plasmid DNA contamination followed by treatment with DNase inactivation reagent according to the manufacturer's instructions. Following purification and treatment, RNA was reverse-transcribed and its corresponding cDNA amplified with primers using the OneStep RT-PCR kit (Invitrogen) and the amplification products were used for sequencing.
Plasmid constructions. To generate recombinant M-segment viruses in the backbone of the WSN33 virus, the M segments from IAVs were cloned into the plasmid pHW2000 as described previously (Hoffmann et al., 2000a, b) . These viruses included: A/swine/Iowa/15/ 30 (H1N1), A/Swine/Missouri/4296424/06 (H2N3), A/Swine/Texas/ 4199-2/98 (H3N2), A/California/04/09 (H1N1) and A/Quail/Hong Kong/G1/97 (H9N2). The resulting plasmids were named pHW-IA30M, pHW-TX98M, pHW-MO06M, pHW-HK97M and pHW-CA09M. To generate chimeric M1 segments, we used standard PCR and cloning methods. We generated M1 substitution constructs by replacing the native M1 coding sequence in the WSN33 M segment with each of the five sequences encoding M1 from other IAVs as listed above. The coding sequence for the WSN33 M2 was not altered in these chimeric M segments, which were designated pHW-IA30M1+WSN-M2, pHW-HK97M1+WSN-M2, pHW-TX98M1+ WSN-M2, pHW-MO06M1+WSN-M2 and pHW-CA09M1+WSN-M2, respectively. Primers and protocols for generation of these constructs will be provided upon request.
Production of infectious IAVs by reverse genetics. WT A/WSN/ 33, recombinant M-segment and chimeric M1 viruses were produced by the reverse genetic technique as described previously (Hoffmann et al., 2000b) . Briefly, to rescue the WT WSN virus, 293T and MDCK cells were co-cultured at approximately 70 % confluence in 12-well plates and transfected with a mixture of eight plasmids (pHW181-PB2, pHW182-PB1, pHW183-PA, pHW184-HA, pHW185-NP, pHW186-NA, pHW187-M and pHW188-NS), which were prepared in Trans-LT1 (Mirus) and Opti-MEM I medium according to the manufacturer's instructions. Recombinant M-segment and chimeric M1 viruses were generated in the same way but substituting the pHW187-M with the plasmid containing the M or chimeric M1 segment as mentioned in the plasmid constructions' section. The mixtures were incubated at room temperature for 45 min before they were added to the cells. After 6 h culture, transfection mixtures were replaced with Opti-MEM I medium followed by an additional 18 h incubation at 37 uC. Then, Opti-MEM I medium containing tosylsulfonyl phenylalanyl chloromethyl ketone (TPCK)-trypsin (Sigma-Aldrich) at a concentration of 1 mg ml 21 was added to each well. At 72 h post-transfection, viral supernatants were collected, centrifuged at 2000 r.p.m. (Sorvall Legend Mach 1.6R, rotor 75003348) for 10 min, aliquoted and stored at 280 uC until further analysis. The resulting viruses were the WT (rWSN), recombinant M (rWSN-IA30M, rWSN-HK97M, rWSN-TX98M, rWSN-MO06M and rWSN-CA09M) and chimeric M1 (rWSN-IA30M1, rWSN-HK97M1, rWSN-TX98M1, rWSN-MO06M1 and rWSN-CA09M1) viruses and were confirmed by sequencing.
Replication kinetics and plaque assay. Studies on viral replication kinetics were performed on a monolayer of MDCK cells using an inoculum of 0.001 m.o.i. Viral samples were collected at 0, 24, 48 and 72 h p.i., respectively. After centrifugation at 2000 r.p.m. (Sorvall Legend Mach 1.6R, rotor 75003348) for 10 min to remove cellular debris, samples were stored at 280 uC until they were titrated by plaque assay.
The conventional plaque assay was performed to measure viral infectivity as described previously (Burleigh et al., 2005) . Confluent MDCK cells grown in 12-well plates were infected with 0.5 ml of 10-fold series dilutions of viral samples. After 1 h incubation at 37 uC, unabsorbed viruses were removed by washing with PBS, and infected monolayers were overlaid with 1.5 ml of overlay medium containing 26 DMEM supplemented with 0.3 % BSA, 2 mg TPCK-trypsin ml 21 , and 1.8 % agar. After 3 days incubation at 37 uC, the overlay was removed and cells were fixed and stained with 0.1 % crystal violet (Acros; dissolved in 10 % formaldehyde solution) for 30 min at room temperature. The plates were gently rinsed with water to remove excess stain followed by air-drying for 10 min at room temperature. Titres (p.f.u.) were calculated by the counting the number of plaques and multiplying this value by the reciprocal of the dilution factor. Concentrated virions and cell lysates were separated by 12 % SDS-PAGE and transferred to a nitrocellulose membrane. After blocking, the membranes were incubated with mouse anti-influenza A matrix protein (AbD Serotec) followed by hybridization with goat antimouse IgG-HRP (Sigma). The protein bands were visualized on film using an ECL system (Pierce). The M1 bands were analysed by ImageJ software (http://rsbweb.nih.gov/ij/) to quantify the percentage of M1 protein expression level of respective chimeric virus relative to WT rWSN.
SDS-PAGE and
HA and NA activity assay. NA activity was measured by using the standard fluorescent assay. The clarified supernatant and fluorogenic substrate MUNANA (Sigma) were added to a 96-well plate, mixed and incubated at 37 uC for 1 h. After stopping the reaction by adding 50 mM glycine buffer, fluorescence was measured in a fluorometer with an excitation wavelength of 355 nm and an emission wavelength of 460 nm, and relative fluorescent units (RFUs) were recorded. A micro-haemagglutination assay (WHO. Manual for the laboratory diagnosis and virological surveillance of influenza. 2011, http://www.who.int/influenza/resources/document/manual diagnosis surveillance influenza/en/index.html) was used to detect the HA titre of viruses with 0.5 % turkey red blood cells.
Mouse study. Animal research was conducted in a Biosafety Level 2 animal facility under the guidance of Kansas State University's Institutional Animal Care and Use Committee. Six-week-old female BALB/c mice (Charles River Laboratories) were randomly divided into six groups (13 mice per group). Mice were anaesthetized with isoflurane USP (Phoenix Pharmaceutical) and intranasally inoculated with a 50 ml volume containing either virus-free MEM (i.e. negative control) or with 5610 3 p.f.u. of each of six isogenic influenza H1N1 WSN33 viruses differing only in the M1 proteins: rWSN (with native M1), rWSN-IA30M1, rWSN-HK97M1, rWSN-TX98M1, rWSN-MO06M1 and rWSN-CA09M1. Mice were monitored daily for weight loss, survival and general health status for a period of 14 days. After the onset of disease, general health status was recorded twice daily. Mice with a weight loss of more than 25 % of the initial body weight prior to virus infection were euthanized and recorded as dead. Three mice from each group were euthanized at day 3 and 5 p.i., respectively, and all other mice were euthanized at day 14 p.i. During necropsy, the right lung was collected and stored at 280 uC for later analysis, and the left lung was fixed in 10 % formalin for histopathologic assessment (Liu et al., 2011) . Haematoxylin and eosin staining was performed as the routine procedure (Sheehan & Hrapchak, 1980) . Virus detection was performed in a 10 % tissue homogenate in PBS that had been homogenized twice for 1 min in a Mini BeadBeater-8 (Biospec Products). The homogenate was centrifuged at 640 g for 5 min, and the supernatant was transferred to 1.5 ml reaction tubes for virus isolation and titration in MDCK cells as described previously (Richt et al., 2003) .
Statistical analysis. Virus titres, weight loss, microscopic lung lesion scores and mortality were analysed by using analysis of variance (ANOVA) in GraphPad Prism version 5.0 (GraphPad software); a P value of 0.05 or less was considered significant. Those response variables shown to have a significant effect by treatment group were subjected to comparisons for all pairs by using the Tukey-Kramer test. Pair-wise mean comparisons between inoculated and control groups were made using the Student's t-test.
